NYSE - Delayed Quote • USD
Teleflex Incorporated (TFX)
At close: 4:00 PM EDT
After hours: 4:38 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 14 | 14 | 15 | 14 |
Avg. Estimate | 3.07 | 3.4 | 13.73 | 15.26 |
Low Estimate | 3.04 | 3.35 | 13.54 | 15 |
High Estimate | 3.13 | 3.52 | 13.83 | 16.05 |
Year Ago EPS | 3.09 | 3.41 | 13.52 | 13.73 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 13 | 13 | 15 | 14 |
Avg. Estimate | 726.89M | 773.25M | 3.09B | 3.27B |
Low Estimate | 724.8M | 767.29M | 3.08B | 3.23B |
High Estimate | 729M | 778.8M | 3.11B | 3.3B |
Year Ago Sales | 710.93M | -- | 2.97B | 3.09B |
Sales Growth (year/est) | 2.20% | -- | 4.00% | 5.60% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 2.97 | 3.21 | 3.27 | 3.26 |
EPS Actual | 3.09 | 3.41 | 3.64 | 3.38 |
Difference | 0.12 | 0.2 | 0.37 | 0.12 |
Surprise % | 4.00% | 6.20% | 11.30% | 3.70% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 3.07 | 3.4 | 13.73 | 15.26 |
7 Days Ago | 3.07 | 3.4 | 13.73 | 15.26 |
30 Days Ago | 3.07 | 3.4 | 13.73 | 15.26 |
60 Days Ago | 3.12 | 3.44 | 13.84 | 15.59 |
90 Days Ago | 3.13 | 3.44 | 13.87 | 15.67 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | TFX | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -0.60% | -- | -- | 1.60% |
Next Qtr. | -0.30% | -- | -- | 10.50% |
Current Year | 1.60% | -- | -- | 5.20% |
Next Year | 11.10% | -- | -- | 13.30% |
Next 5 Years (per annum) | 7.20% | -- | -- | 11.22% |
Past 5 Years (per annum) | 6.84% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
Earnings
Upgrades & Downgrades
Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/23/2024 |
Maintains | RBC Capital: Outperform to Outperform | 2/23/2024 |
Maintains | Truist Securities: Hold to Hold | 2/23/2024 |
Maintains | RBC Capital: Outperform to Outperform | 1/12/2024 |
Maintains | Truist Securities: Hold to Hold | 12/22/2023 |
Maintains | Raymond James: Outperform to Outperform | 12/20/2023 |
Related Tickers
COO The Cooper Companies, Inc.
90.42
+0.01%
MMSI Merit Medical Systems, Inc.
72.03
+1.46%
WST West Pharmaceutical Services, Inc.
372.04
-1.40%
ICUI ICU Medical, Inc.
95.77
-1.17%
UTMD Utah Medical Products, Inc.
68.58
+2.01%
XRAY DENTSPLY SIRONA Inc.
30.50
+0.20%
HOLX Hologic, Inc.
75.38
+0.37%
ANGO AngioDynamics, Inc.
6.26
+2.29%
OSUR OraSure Technologies, Inc.
5.28
+0.57%
ATRI Atrion Corporation
402.35
+4.32%